Physician profile
Kirk Geter
NPI 1689756884
$1,370.19
in general payments reported to CMS, 2019-2025
11 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.92 · 2020: $40.79 · 2021: $129 · 2022: $271 · 2023: $205 · 2024: $193 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $795.64 | 2019-2025 | Stravix Pl, Grafix Pl, Collagenase Santyl |
| Integra Lifesciences Corporation | $174.71 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Kerecis Limited | $149.17 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Medtronic, INC. | $60.87 | 2023 | Intellis Adaptivestim |
| Polynovo North America LLC | $59.82 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $41.39 | 2024-2025 | Gore Synecor Biomaterial |
| Tactile Systems Technology INC | $22.02 | 2025 | Flexitouch Plus, Nimbl |
| Avita Medical Americas, LLC | $19.34 | 2025 | Cohealyx, Permeaderm, Recell |
| Allergan, INC. | $18.50 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $15.42 | 2023 | |
| Kci USA, INC. | $13.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Geter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.